Differentiating neurosarcoidosis from multiple sclerosis using combined analysis of basic CSF parameters and MRZ reaction

Distinguishing CNS neurosarcoidosis from multiple sclerosis and an approach to “overlap” cases

(2022) Fiona Chan et al.   JOURNAL OF NEUROIMMUNOLOGY

Sarcoidosis and obsessive-compulsive symptoms

(2022) Dominique Endres et al.   JOURNAL OF NEUROIMMUNOLOGY

Likelihood Ratio Approach and Clinical Interpretation of Laboratory Tests

(2021) Walter Fierz et al.   Frontiers in Immunology

2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis

(2021) Mike P Wattjes et al.   LANCET NEUROLOGY

Clinical characterization and outcomes of 85 patients with neurosarcoidosis

(2021) Manuel Ramos-Casals et al.   Scientific Reports

Neurosarcoidosis mimicry of MS: Clues from cases with CNS tissue diagnosis

(2021) Thomas F. Scott   JOURNAL OF THE NEUROLOGICAL SCIENCES

Neurosarcoidosis

(2021) Michael J. Bradshaw et al.   Neurology-Neuroimmunology & Neuroinflammation

Distinguishing neurosarcoidosis from multiple sclerosis based on CSF analysis

(2020) Tarunya Arun et al.   NEUROLOGY

Analysis of soluble interleukin-2 receptor as CSF biomarker for neurosarcoidosis

(2020) Carolin Otto et al.   Neurology-Neuroimmunology & Neuroinflammation

Cerebrospinal fluid CD4 + /CD8 + ratio in diagnosing neurosarcoidosis

(2020) Sara Nordström et al.   ACTA NEUROLOGICA SCANDINAVICA

Prevalence and incidence of neuromyelitis optica spectrum disorder, aquaporin-4 antibody-positive NMOSD and MOG antibody-positive disease in Oxfordshire, UK

(2020) Karen O'Connell et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Biomarkers in the Diagnosis and Prognosis of Sarcoidosis: Current Use and Future Prospects

(2020) Raisa Kraaijvanger et al.   Frontiers in Immunology

Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide

(2020) Jyh Yung Hor et al.   Frontiers in Neurology

The cerebrospinal fluid CD 4/ CD 8 ratio and interleukin‐6 and ‐10 levels in neurosarcoidosis: a multicenter, pragmatic, comparative study

(2019) Thibaud Chazal et al.   EUROPEAN JOURNAL OF NEUROLOGY

Incidence of pediatric neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease in Denmark 2008‒2018: A nationwide, population-based cohort study

(2019) Magnus S. Boesen et al.   Multiple Sclerosis and Related Disorders

Focus on increased serum angiotensin-converting enzyme level: From granulomatous diseases to genetic mutations

(2018) Marilucy Lopez-Sublet et al.   CLINICAL BIOCHEMISTRY

Sarcoidosis of the central nervous system: clinical features, imaging, and CSF results

(2018) Desmond P. Kidd   JOURNAL OF NEUROLOGY

Definition and Consensus Diagnostic Criteria for Neurosarcoidosis

(2018) Barney J. Stern et al.   JAMA Neurology

Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in Denmark

(2018) Viktoria Papp et al.   NEUROLOGY

CSF and clinical data are useful in differentiating CNS inflammatory demyelinating disease from CNS lymphoma

(2017) Ryotaro Ikeguchi et al.   Multiple Sclerosis Journal

Characteristics and Long-Term Outcome of Neurosarcoidosis: A Population-Based Study from 1976-2013

(2017) Patompong Ungprasert et al.   NEUROEPIDEMIOLOGY

Infliximab for the treatment of CNS sarcoidosis

(2017) Jeffrey M. Gelfand et al.   NEUROLOGY

Abnormal cervical lymph nodes in multiple sclerosis: a preliminary ultrasound study

(2017) Francesca Di Giuliano et al.   Radiologia Medica

Association of Prognostic Factors and Immunosuppressive Treatment With Long-term Outcomes in Neurosarcoidosis

(2017) Bastien Joubert et al.   JAMA Neurology

CSF and clinical data are useful in differentiating CNS inflammatory demyelinating disease from CNS lymphoma

(2017) Ryotaro Ikeguchi et al.   Multiple Sclerosis Journal

Clinical features, treatment and outcome in neurosarcoidosis: systematic review and meta-analysis

(2016) Daan Fritz et al.   BMC Neurology

Sarcoidosis incidence and prevalence: a nationwide register-based assessment in Sweden

(2016) Elizabeth V. Arkema et al.   EUROPEAN RESPIRATORY JOURNAL

The MRZ reaction as a highly specific marker of multiple sclerosis: re-evaluation and structured review of the literature

(2016) S. Jarius et al.   JOURNAL OF NEUROLOGY

Genetics of Sarcoidosis

(2015) Tasha E. Fingerlin et al.   CLINICS IN CHEST MEDICINE

Diagnostic Accuracy Measures

(2014) Paolo Eusebi   CEREBROVASCULAR DISEASES

CNS inflammation other than multiple sclerosis: How likely is diagnosis?

(2014) D. Street et al.   NEUROLOGY

Cranial Base Manifestations of Neurosarcoidosis

(2014) Matthew L. Carlson et al.   OTOLOGY & NEUROTOLOGY

Genetic Susceptibility to Sarcoidosis, a Chronic Inflammatory Disorder

(2012) Coline H. M. van Moorsel et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

A Novel Sarcoidosis Risk Locus for Europeans on Chromosome 11q13.1

(2012) Annegret Fischer et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Diagnostic pitfalls: a case of neurosarcoidosis mimicking tuberculous meningitis

(2012) Franziska Scheibe et al.   JOURNAL OF NEUROLOGY

Intrathecal, Polyspecific Antiviral Immune Response in Oligoclonal Band Negative Multiple Sclerosis

(2012) Isabel Brecht et al.   PLoS One

Soluble CSF interleukin 2 receptor as indicator of neurosarcoidosis

(2010) Hela-Felicitas Petereit et al.   JOURNAL OF NEUROLOGY

Neurosarcoidosis Mimicry of Multiple Sclerosis

(2010) Thomas F. Scott et al.   NEUROLOGIST

Immune-mediated and chronic inflammatory disease in people with sarcoidosis: disease associations in a large UK database

(2009) N Rajoriya et al.   POSTGRADUATE MEDICAL JOURNAL

Presentations and outcomes of neurosarcoidosis: a study of 54 cases

(2009) S. Pawate et al.   QJM-AN INTERNATIONAL JOURNAL OF MEDICINE

Neurosarcoidosis: a study of 30 new cases

(2008) F G Joseph et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY